Detalhe da pesquisa
1.
A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy.
J Clin Oncol
; 9(5): 721-8, 1991 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-1826739
2.
Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
J Clin Oncol
; 8(12): 1951-8, 1990 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1700079
3.
Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting.
J Clin Oncol
; 10(12): 1969-75, 1992 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1453211
4.
Prevention of acute emesis in cancer patients following high-dose cisplatin with the combination of oral dolasetron and dexamethasone.
J Clin Oncol
; 15(5): 2135-8, 1997 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-9164228
5.
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
J Clin Oncol
; 15(4): 1318-32, 1997 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-9193323
6.
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centers.
Bone Marrow Transplant
; 20(9): 753-60, 1997 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-9384477
7.
Efficacy of oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment of nausea and vomiting associated with cyclophosphamide-based chemotherapies. Ondansetron Study Group.
Am J Clin Oncol
; 17(2): 137-46, 1994 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8141105
8.
Options in the treatment of chemotherapy-induced emesis.
Cancer Pract
; 6(5): 276-81, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-9767346
9.
Randomized phase III study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer.
Cancer
; 76(10): 1709-14, 1995 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-8625038
10.
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
N Engl J Med
; 340(3): 190-5, 1999 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-9917226
11.
Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.
Cancer J Sci Am
; 3(1): 45-51, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9072308
12.
Intensive timed sequential combination chemotherapy in extensive-stage small cell carcinoma of the lung.
Cancer Treat Rep
; 66(10): 1880, 1982 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-6290052